Conclusion: Taxotere as a single agent therapy is effective.
结论：单药泰索帝治疗晚期乳腺癌疗效肯定。
Between the two taxanes, both Taxol and Taxotere are reasonable options to combine with Adriamycin for our patient.
在2个紫杉类药物中，泰素和泰索帝与阿霉素联合均为合理的选择。
Unfortunately, a study of a similar design has not been performed with Taxotere. This agent, on the other hand, has shown.
很惋惜，泰索帝未做相同计划的临床研究。但另一方面，泰索帝显示。
Objective to observe the efficacy, toxicity and survival of Taxotere and Cisplatin regimen in advanced non? - small cell lung cancer.
目的观察泰素蒂加顺铂方案治疗进展期非小细胞肺癌的临床疗效、毒副作用。
Taxotere and CPT-11 appear to hold more promise in the investigation of patients with AGC than drugs like oxaliplatin, S-1, or many new classes of compounds that are under early investigation.
在晚期胃癌的临床研究中，泰索帝和开普拓（CPT-11）比奥沙利铂、S-1和其他正在进行早期研究的新药显得更有发达前景。
Taxotere and CPT-11 appear to hold more promise in the investigation of patients with AGC than drugs like oxaliplatin, S-1, or many new classes of compounds that are under early investigation.
在晚期胃癌的临床研究中，泰索帝和开普拓（CPT-11）比奥沙利铂、S-1和其他正在进行早期研究的新药显得更有发达前景。
应用推荐